Investors & News / Media Coverage / Media Coverage Year None2025202420222020201920172016 Oct 09, 2025 Lisata Therapeutics CEO Dr David Mazzo on global product license deal with Catalent Jul 18, 2025 WTR Healthcare Spotlight Podcast: Lisata Therapeutics' CEO Dr. David Mazzo and CMO Dr. Kristen Buck on the Promise of certepetide for pancreatic cancer Jul 10, 2025 Lisata Therapeutics and GATC Health see collaboration as the way forward for drug development May 20, 2025 Celebrating Clinical Trials Day, Part 3: Making The Most Of Resources Apr 16, 2025 Lisata Therapeutics CMO discusses potential for certepetide under Catalent license agreement Mar 07, 2025 Lisata Therapeutics expands drug discovery with GATC AI collaboration Jan 23, 2025 Lisata Therapeutics CEO David Mazzo on ASCEND and iLSTA trial results Dec 11, 2024 Lisata Therapeutics advances certepetide with trial enrollment milestone and new diagnostic partnership Dec 03, 2024 Lisata Therapeutics Enters Global Collaboration with Kuva Labs to Advance Tumor Imaging Technology Oct 31, 2024 Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last » Print Page RSS Feeds Email Alerts
Year None2025202420222020201920172016 Oct 09, 2025 Lisata Therapeutics CEO Dr David Mazzo on global product license deal with Catalent Jul 18, 2025 WTR Healthcare Spotlight Podcast: Lisata Therapeutics' CEO Dr. David Mazzo and CMO Dr. Kristen Buck on the Promise of certepetide for pancreatic cancer Jul 10, 2025 Lisata Therapeutics and GATC Health see collaboration as the way forward for drug development May 20, 2025 Celebrating Clinical Trials Day, Part 3: Making The Most Of Resources Apr 16, 2025 Lisata Therapeutics CMO discusses potential for certepetide under Catalent license agreement Mar 07, 2025 Lisata Therapeutics expands drug discovery with GATC AI collaboration Jan 23, 2025 Lisata Therapeutics CEO David Mazzo on ASCEND and iLSTA trial results Dec 11, 2024 Lisata Therapeutics advances certepetide with trial enrollment milestone and new diagnostic partnership Dec 03, 2024 Lisata Therapeutics Enters Global Collaboration with Kuva Labs to Advance Tumor Imaging Technology Oct 31, 2024 Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last »
Jul 18, 2025 WTR Healthcare Spotlight Podcast: Lisata Therapeutics' CEO Dr. David Mazzo and CMO Dr. Kristen Buck on the Promise of certepetide for pancreatic cancer
Jul 10, 2025 Lisata Therapeutics and GATC Health see collaboration as the way forward for drug development
Apr 16, 2025 Lisata Therapeutics CMO discusses potential for certepetide under Catalent license agreement
Dec 11, 2024 Lisata Therapeutics advances certepetide with trial enrollment milestone and new diagnostic partnership
Dec 03, 2024 Lisata Therapeutics Enters Global Collaboration with Kuva Labs to Advance Tumor Imaging Technology
Oct 31, 2024 Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis
